PERSPECTA

News from every angle

← Back to headlines

Novo Nordisk Announces Price Cuts for Ozempic and Wegovy in 2027

Novo Nordisk plans to reduce the prices of its popular weight-loss and diabetes drugs, Ozempic and Wegovy, starting in 2027, a move that could impact patient access and market dynamics.

24 Feb, 13:44 — 24 Feb, 13:44
PostShare
Only 1 source covers this story